Specifically, MS1262 treatment reversed the expression and phosphorylation of SMOC1 in the Aβ-associated matrisome module; SMOC1 was found elevated in AD CSF nearly 30 years before the onset of symptoms28. Here, SMOC1 is linked to Alzheimer disease.